Literature DB >> 27406996

Elite controller CD8+ T cells exhibit comparable viral inhibition capacity, but better sustained effector properties compared to chronic progressors.

David Shasha1, Dan Karel1, Olivia Angiuli1, Adam Greenblatt1, Musie Ghebremichael1, Xu Yu1, Filippos Porichis2, Bruce D Walker3.   

Abstract

Mechanisms modulating HIV-specific CD8+ T cell-mediated viral inhibition are not well defined. To delineate features of effective control, we compared the ability of CD8+ T cells from HIV ECs and CPs to inhibit HIV ex vivo. ECs showed superior inhibition compared to HAART-treated or untreated CPs in a typical VIA in which CD8+ T cells are rested 3 d before use (P = 0.025). In contrast, comparable antiviral activity was observed in freshly thawed cells. Rested CD8+ T cells underwent apoptosis with preferential loss of HIV-specific cells. EC CD8+ T cells showed greater capacity to sustain polyfunctionality ex vivo compared with those of CPs, and incubation of CD8+ T cells with IL-15 augmented inhibition. These results indicate that superior ex vivo inhibition of viral replication by CD8+ T cells from ECs is associated with enhanced retention of functional qualities and that in vitro antiviral function is enhanced by IL-15. © Society for Leukocyte Biology.

Entities:  

Keywords:  HIV control; IL-15; apoptosis; polyfunctionality

Mesh:

Substances:

Year:  2016        PMID: 27406996      PMCID: PMC5109996          DOI: 10.1189/jlb.4A0915-422R

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  49 in total

1.  Elite controllers with low to absent effector CD8+ T cell responses maintain highly functional, broadly directed central memory responses.

Authors:  Zaza M Ndhlovu; Jacqueline Proudfoot; Kevin Cesa; Donna Marie Alvino; Ashley McMullen; Seanna Vine; Eleni Stampouloglou; Alicja Piechocka-Trocha; Bruce D Walker; Florencia Pereyra
Journal:  J Virol       Date:  2012-04-18       Impact factor: 5.103

2.  The Breadth of Expandable Memory CD8+ T Cells Inversely Correlates with Residual Viral Loads in HIV Elite Controllers.

Authors:  Zaza M Ndhlovu; Eleni Stampouloglou; Kevin Cesa; Orestes Mavrothalassitis; Donna Marie Alvino; Jonathan Z Li; Shannon Wilton; Daniel Karel; Alicja Piechocka-Trocha; Huabiao Chen; Florencia Pereyra; Bruce D Walker
Journal:  J Virol       Date:  2015-08-12       Impact factor: 5.103

3.  High-dimensional immunomonitoring models of HIV-1-specific CD8 T-cell responses accurately identify subjects achieving spontaneous viral control.

Authors:  Zaza M Ndhlovu; Lori B Chibnik; Jacqueline Proudfoot; Seanna Vine; Ashley McMullen; Kevin Cesa; Filippos Porichis; R Brad Jones; Donna Marie Alvino; Meghan G Hart; Eleni Stampouloglou; Alicja Piechocka-Trocha; Carl Kadie; Florencia Pereyra; David Heckerman; Philip L De Jager; Bruce D Walker; Daniel E Kaufmann
Journal:  Blood       Date:  2012-12-11       Impact factor: 22.113

4.  Simian immunodeficiency virus (SIV) infection of a rhesus macaque induces SIV-specific CD8(+) T cells with a defect in effector function that is reversible on extended interleukin-2 incubation.

Authors:  Y Xiong; M A Luscher; J D Altman; M Hulsey; H L Robinson; M Ostrowski; B H Barber; K S MacDonald
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

5.  Ex vivo expansion of CD4 lymphocytes from human immunodeficiency virus type 1-infected persons in the presence of combination antiretroviral agents.

Authors:  C C Wilson; J T Wong; D D Girard; D P Merrill; M Dynan; D D An; S A Kalams; R P Johnson; M S Hirsch; R T D'Aquila
Journal:  J Infect Dis       Date:  1995-07       Impact factor: 5.226

6.  Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome.

Authors:  R A Koup; J T Safrit; Y Cao; C A Andrews; G McLeod; W Borkowsky; C Farthing; D D Ho
Journal:  J Virol       Date:  1994-07       Impact factor: 5.103

7.  Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection.

Authors:  P Borrow; H Lewicki; B H Hahn; G M Shaw; M B Oldstone
Journal:  J Virol       Date:  1994-09       Impact factor: 5.103

8.  Programmed death-1 is a marker for abnormal distribution of naive/memory T cell subsets in HIV-1 infection.

Authors:  Gaëlle Breton; Nicolas Chomont; Hiroshi Takata; Rémi Fromentin; Jeffrey Ahlers; Abdelali Filali-Mouhim; Catherine Riou; Mohamed-Rachid Boulassel; Jean-Pierre Routy; Bader Yassine-Diab; Rafick-Pierre Sékaly
Journal:  J Immunol       Date:  2013-08-05       Impact factor: 5.422

9.  A molecular basis for the control of preimmune escape variants by HIV-specific CD8+ T cells.

Authors:  Kristin Ladell; Masao Hashimoto; Maria Candela Iglesias; Pascal G Wilmann; James E McLaren; Stéphanie Gras; Takayuki Chikata; Nozomi Kuse; Solène Fastenackels; Emma Gostick; John S Bridgeman; Vanessa Venturi; Zaïna Aït Arkoub; Henri Agut; David J van Bockel; Jorge R Almeida; Daniel C Douek; Laurence Meyer; Alain Venet; Masafumi Takiguchi; Jamie Rossjohn; David A Price; Victor Appay
Journal:  Immunity       Date:  2013-03-21       Impact factor: 31.745

10.  Self-class I MHC molecules support survival of naive CD8 T cells, but depress their functional sensitivity through regulation of CD8 expression levels.

Authors:  Kensuke Takada; Stephen C Jameson
Journal:  J Exp Med       Date:  2009-09-14       Impact factor: 14.307

View more
  13 in total

1.  T cell receptors for the HIV KK10 epitope from patients with differential immunologic control are functionally indistinguishable.

Authors:  Alok V Joglekar; Zhe Liu; Jeffrey K Weber; Yong Ouyang; John D Jeppson; Won Jun Noh; Pedro A Lamothe-Molina; Huabiao Chen; Seung-Gu Kang; Michael T Bethune; Ruhong Zhou; Bruce D Walker; David Baltimore
Journal:  Proc Natl Acad Sci U S A       Date:  2018-02-07       Impact factor: 11.205

2.  HIV elite control is associated with reduced TRAILshort expression.

Authors:  Ana C Paim; Nathan W Cummins; Sekar Natesampillai; Enrique Garcia-Rivera; Nicole Kogan; Ujjwal Neogi; Anders Sönnerborg; Maike Sperk; Gary D Bren; Steve Deeks; Eric Polley; Andrew D Badley
Journal:  AIDS       Date:  2019-09-01       Impact factor: 4.177

3.  Metabolic pathway activation distinguishes transcriptional signatures of CD8+ T cells from HIV-1 elite controllers.

Authors:  Fatema Z Chowdhury; Zhengyu Ouyang; Maria Buzon; Bruce D Walker; Mathias Lichterfeld; Xu G Yu
Journal:  AIDS       Date:  2018-11-28       Impact factor: 4.177

4.  Role of IL-15 Signaling in the Pathogenesis of Simian Immunodeficiency Virus Infection in Rhesus Macaques.

Authors:  Afam A Okoye; Maren Q DeGottardi; Yoshinori Fukazawa; Mukta Vaidya; Chike O Abana; Audrie L Konfe; Devin N Fachko; Derick M Duell; He Li; Richard Lum; Lina Gao; Byung S Park; Rebecca L Skalsky; Anne D Lewis; Michael K Axthelm; Jeffrey D Lifson; Scott W Wong; Louis J Picker
Journal:  J Immunol       Date:  2019-10-25       Impact factor: 5.422

Review 5.  CD8+ T cells in HIV control, cure and prevention.

Authors:  David R Collins; Gaurav D Gaiha; Bruce D Walker
Journal:  Nat Rev Immunol       Date:  2020-02-12       Impact factor: 53.106

Review 6.  Understanding the CD8 T-cell response in natural HIV control.

Authors:  Sushma Boppana; Paul Goepfert
Journal:  F1000Res       Date:  2018-07-02

Review 7.  Association of Diverse Genotypes and Phenotypes of Immune Cells and Immunoglobulins With the Course of HIV-1 Infection.

Authors:  Liuzhe Li; Yan Liu; Miroslaw K Gorny
Journal:  Front Immunol       Date:  2018-11-26       Impact factor: 7.561

8.  A Highly Unusual V1 Region of Env in an Elite Controller of HIV Infection.

Authors:  Zachary A Silver; Gordon M Dickinson; Michael S Seaman; Ronald C Desrosiers
Journal:  J Virol       Date:  2019-05-01       Impact factor: 5.103

9.  Current Treatment Options for HIV Elite Controllers: a Review.

Authors:  Katherine Promer; Maile Y Karris
Journal:  Curr Treat Options Infect Dis       Date:  2018-04-16

Review 10.  Immunological effector mechanisms in HIV-1 elite controllers.

Authors:  Ciputra Adijaya Hartana; Xu G Yu
Journal:  Curr Opin HIV AIDS       Date:  2021-09-01       Impact factor: 4.061

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.